Abstract | INTRODUCTION: METHODS: We undertook a retrospective review of consecutive patients with MoM-HP referred for outpatient review in toxicology clinics in London, UK, and in the USA recorded in the Toxicology Investigators Consortium (ToxIC) Registry from June 2011 to June 2015. RESULTS: Thirty-one cases were identified; the median (IQR) serum cobalt concentration was 10.0 (3.8-32.8) mcg/L, and the median (IQR) serum chromium concentration was 6.9 (3.7-18.7) mcg/L. Twenty-three (74.2%) had symptoms, most commonly lethargy, hearing loss, and tinnitus. The odds ratios of symptomatic/asymptomatic patients for metal ion concentrations above/below 7 mcg/L were 1.87 (95% CI 0.37-9.57, p = 0.45) and 0.60 (95% CI 0.10-3.50, p = 0.57) for cobalt and chromium, respectively. Two (6.5%) patients with systemic cobalt toxicity had median (IQR) serum cobalt concentrations significantly higher than those without systemic features (630.4 [397.6-863.2] mcg/L versus 9.8 [2.9-16.4] mcg/L; p = 0.017). However, overall, there were no differences between cobalt (p = 0.38) or chromium (p = 0.92) concentrations between symptomatic and asymptomatic patients and no clinical features or investigation results correlated with cobalt or chromium concentration. CONCLUSION: Two (6.5%) of 31 individuals referred for assessment of MoM-HP were diagnosed with systemic cobalt toxicity. However, despite a high prevalence of reported symptoms, neither symptoms nor investigation results correlated with serum cobalt or chromium concentrations.
|
Authors | James H Ho, Jerrold B Leikin, Paul I Dargan, John R H Archer, David M Wood, Jeffrey Brent |
Journal | Journal of medical toxicology : official journal of the American College of Medical Toxicology
(J Med Toxicol)
Vol. 13
Issue 4
Pg. 321-328
(12 2017)
ISSN: 1937-6995 [Electronic] United States |
PMID | 28900863
(Publication Type: Journal Article, Multicenter Study)
|
Chemical References |
- Biomarkers
- Chromium
- Cobalt
|
Topics |
- Aged
- Arthroplasty, Replacement, Hip
(adverse effects, instrumentation)
- Biomarkers
(blood)
- Chromium
(blood, poisoning)
- Cobalt
(blood, poisoning)
- Female
- Hip Prosthesis
(adverse effects)
- Humans
- London
(epidemiology)
- Male
- Metal-on-Metal Joint Prostheses
(adverse effects)
- Middle Aged
- Odds Ratio
- Poisoning
(blood, diagnosis, epidemiology)
- Prevalence
- Prosthesis Failure
- Registries
- Retrospective Studies
- Risk Factors
- Time Factors
- Treatment Outcome
- United States
(epidemiology)
|